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Originating Technology/NASA Contribution
Since the earliest missions in space, NASA special-ists have performed experiments in low gravity. Protein crystal growth, cell and tissue cultures, 
and separation technologies such as electrophoresis 
and magnetophoresis have been studied on Apollo 14, 
Apollo 16, STS-107, and many other missions. 
Electrophoresis and magnetophoresis, respectively, are 
processes that separate substances based on the electrical 
charge and magnetic field of a molecule or particle. 
Electrophoresis has been studied on over a dozen space 
shuttle flights, leading to developments in electrokinetics, 
which analyzes the effects of electric fields on mass 
transport (atoms, molecules, and particles) in fluids. 
Further studies in microgravity will continue to improve 
these techniques, which researchers use to extract cells for 
various medical treatments and research.
Partnership
As part of the NASA Shuttle Student Involvement 
Program, John Vellinger designed an experiment to 
study the effect of low gravity on chicken embryos. 
After his freshman year at Purdue University in 1985, 
Vellinger partnered with KFC Corporation staff engineer, 
Mark Deuser, who helped Vellinger design the “Chix 
in Space” experiment for two space shuttle missions. 
Their work together laid the foundation for creating 
Space Hardware Optimization Technology Inc. (SHOT) 
in 1988, after acquiring a NASA contract for space flight 
hardware development. 
Since 1988, four NASA centers—Marshall Space 
Flight Center, Glenn Research Center, Johnson Space 
Center, and Ames Research Center—have issued over 
25 Small Business Innovation Research (SBIR) con-
tracts to the Greenville, Indiana-based company, which 
has since changed its name to Techshot Inc. For its first 
13 years, Techshot served exclusively as a NASA pay-
load company, specializing in space hardware and later, 
separation technologies. Techshot engineers designed and 
integrated hardware for three suborbital rocket flights, 
seven space shuttle missions, and several payloads for the 
International Space Station. 
Working with the Consortium for Materials 
Development in Space at the University of Alabama in 
Huntsville, Techshot won a contract to develop separation 
technologies for space application. Separation technolo-
gies involve the analysis and purification of proteins or 
“markers” which reveal information about diseases and 
the body. With the addition of Paul Todd as chief sci-
entist in 2000, Techshot realized the value of terrestrial 
applications of separation technology, and explored 
experimental possibilities with Marshall and Johnson. 
Product Outcome
Accustomed to working with the exacting require-
ments for space payloads, Techshot took a logical step 
in commercializing separation technology for the equally 
strict medical field, beginning with an organic separa-
tor developed for the Organic Separation Experiment 
that first flew on STS-57. Next, the company devel-
oped advanced separators based on the Advanced 
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Payload Specialist John Glenn worked with Techshot’s 
ADSEP hardware aboard Space Shuttle Discovery on STS-95.
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Space Experiment Processor (ADSEP), operated in low 
gravity without using a centrifugal field. These tech-
nologies provide biphasic, electrophoretic, and magnetic 
separation capabilities. 
During early development of these separators, 
Techshot found the number of cells collected was insuf-
ficient for the needs of the experiment, for example, in 
stem cell transplants. To remedy this, Techshot purchased 
the license for a magnetic separation technology from the 
Cleveland Clinic Foundation, already shown to produce 
enough cells for a stem cell transplant. The resulting 
system—Magsort—is a multistage electromagnetic 
separator for purifying cells and magnetic particles for a 
variety of research and medical uses, including stem cell 
research and cancer treatment, in a much more refined 
manner than previously possible. 
A laboratory apparatus for separating particles (espe-
cially biological cells), Magsort separates cells based on 
their magnetic susceptibility and magnetophoretic mobil-
ity. Magsort refines a sample population of particles by 
categorizing multiple portions of the sample and separat-
ing substances into individual parts, instead of as entire 
sets. As Todd explains, “If you have a mixture of cells—A, 
B, C, and D—Magsort will separate and collect A and B 
and C and D and put them separately in the hands of a 
research investigator . . . . Other existing methods would 
sort out only B, for example.” 
The cells of interest might only be present in low 
numbers, so refined separation techniques are necessary 
for effective research. In its magnetophoretic process, the 
Magsort creates magnetic particles that are smaller than 
the cell but react only to one certain cell type. The hema-
tological stem cells, for example, have molecules on their 
surface (clusters of differentiation 34) that can react with 
an antibody and then attach to a magnetic particle. If the 
mixture is then placed in a magnetic field, only the stem 
cells will be drawn to the magnet.
Magsort includes an electronic unit coupled to a built-
in computer and a processing unit that includes horizontal 
upper and lower plates, a plate rotation system, a graded 
series of capture magnets above the upper plate, and a 
wheel for sequencing the small permanent capture mag-
nets. The bolted plates rotate, and an interface between 
them acts as a seal for separating fluids. Up to 15 upper 
cuvette stations allow for fraction collection; a stepping 
motor drives the rotation system, causing the upper plate 
to rotate for fractional sample collection. User interface 
software displays the status of the various components on 
a small organic light-emitting diode (LED) monitor: the 
translating electromagnet, capture magnet, and the rota-
tion of the upper plate. 
Techshot is currently developing other separation 
products for the medical field. A Techshot spinoff 
company, IKOTech LLC, is commercializing a version 
of the Magsort called the Quadruple Magnetic Sorter; 
it is used primarily for stem cell processes and cancer 
Techshot and IKOTech licensed and commercialized this Quadruple Magnetic Sorter, which uses magnetophoresis for cancer 
research and stem cell processes.
research and treatment, including the detection of rare 
cancer cells and the removal of undesired cells from bone 
marrow transplants. Another model is being developed for 
type 1 diabetes pancreas islet transplants. Todd explains, 
“Right now, it takes two or three donor organs to treat 
one person. Our process greatly increases the yield.” With 
enough healthy (transplanted) beta cells of their own, 
patients’ symptoms could vanish. 
Techshot credits the success of their separation 
technologies with their years of experience with NASA, 
and consider the company itself a spinoff. Rich Boling, 
vice president of corporate advancement, claims 
that Techshot’s years of experience in payloads made 
their commercial separators possible, as their capabilities 
as a company were “refined in the crucible of human 
space flight.” v
